When given early, the antiviral drug molnupiravir (Lagevrio) halved the risk of COVID-19 death and reduced all-cause deaths among older adults in the Czech Republic in 2022, findings published ...
A live webcast of the presentation will be available here and on the Company’s website at https://ir.ateapharma.com/. An archived webcast will be available on Atea Pharmaceuticals’ website for at ...
A research article shows that Eradivir's patent-pending antiviral therapeutic called EV25 reduces lung viral loads of advanced-stage influenza in preclinical studies quicker and more effectively than ...